Tritschler Tobias, Kraaijpoel Noémie, Girard Philippe, Büller Harry R, Langlois Nicole, Righini Marc, Schulman Sam, Segers Annelise, Le Gal Grégoire
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769.
Pulmonary embolism (PE)-related death is often a component of the primary outcome in venous thromboembolism (VTE) clinical studies. Definitions for PE-related death vary widely, which may lead to biased risk estimates of clinical outcomes, thereby affecting both internal and external validity of study results. We here provide a standardized definition of PE-related death and propose guidance for classification and reporting of the cause of death for clinical studies in VTE. The proposal was developed in a four-step process, including a systematic review of definitions used for PE-related death in previous studies, two subsequent surveys with VTE experts, and meetings held within the Scientific and Standardization Committee (SSC) working group until consensus on the proposal was reached. The proposed classification comprises three categories: Category A: PE-related death, category B: undetermined cause of death, and category C: cause of death other than PE. Category A includes A1: autopsy-confirmed PE in the absence of another more likely cause of death; A2: objectively confirmed PE before death in the absence of another more likely cause of death; and A3: PE is not objectively confirmed, but is most likely the main cause of death. Category B includes B1: cause of death is undetermined, despite available information; and B2: insufficient clinical information available to determine the cause of death. The use of the proposed definition will hopefully improve the accuracy of study outcomes, between-study comparisons, meta-analyses, and validity of future clinical VTE studies.
肺栓塞(PE)相关死亡通常是静脉血栓栓塞症(VTE)临床研究主要结局的一个组成部分。PE相关死亡的定义差异很大,这可能导致临床结局风险估计出现偏差,从而影响研究结果的内部和外部有效性。我们在此提供PE相关死亡的标准化定义,并为VTE临床研究中死亡原因的分类和报告提出指导意见。该提议是通过四个步骤制定的,包括对以往研究中PE相关死亡所用定义的系统回顾、随后对VTE专家进行的两项调查,以及在科学与标准化委员会(SSC)工作组内举行的会议,直至就该提议达成共识。提议的分类包括三类:A类:PE相关死亡;B类:死亡原因未确定;C类:非PE导致的死亡。A类包括A1:尸检确诊为PE且无其他更可能的死亡原因;A2:死前客观确诊为PE且无其他更可能的死亡原因;A3:PE未得到客观证实,但很可能是主要死亡原因。B类包括B1:尽管有可用信息,但死亡原因仍未确定;B2:没有足够的临床信息来确定死亡原因。使用提议的定义有望提高研究结局的准确性、研究间比较、荟萃分析以及未来临床VTE研究的有效性。